The lower prices stem from the Medicare negotiation program created under the Biden administration's Inflation Reduction Act.

President Joe Biden said during an Oct. 21 town hall that expanding Medicare would be an uphill battle. While President Biden said the cost of expanding Medicare could be mitigated, he expressed ...

Medicare will save approximately $12 billion, or 44%, on 15 high-cost medications as a result of the second round of the program’s drug price negotiations, the Trump administration announced Tuesday ...

Vice President Joe Biden’s goal of cutting $1 trillion from the federal budget could include cuts to Medicare, according to a Bloomberg report. In discussions with Congressional leaders, Mr. Biden ...

WASHINGTON — President Joe Biden is trumpeting Medicare’s new powers to negotiate directly with drugmakers on the cost of prescription medications — but a poll shows any immediate political boost that ...

The Trump administration rejected a Biden-era plan that would have required Medicare and Medicaid to cover obesity drugs like Ozempic and expand access to them for millions of Americans. The Friday ...

Medicaid issues are turning up as winners in President Joe Biden’s social agenda framework even as divisions force Democrats to hit pause on far-reaching improvements to Medicare. The budget blueprint ...

WASHINGTON (AP) -- Vice President Joe Biden cited job gains under President Barack Obama while ignoring overall job losses, standard fare at the Democratic National Convention. And he laced into ...

Independent Vermont Senator and Democratic presidential candidate Bernie Sanders compared rival Joe Biden with President Donald Trump, saying that the former vice president “sounds like Donald Trump” ...

President Trump's Justice Department will defend Biden's Inflation Reduction Act and its dangerous price controls on prescription drugs in federal court. AFP via Getty Images The Trump administration ...

WASHINGTON -- The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded coverage of costly anti-obesity drugs to more than 7 million ...